• TechCrunch
• CrunchBase
• More
  • TechCrunch Europe
  • TechCrunch France
  • TechCrunch Japan

Nexus Medical Partners

edit

The Nexus Group is a private equity firm managing several funds with offices in Massachusetts and South Carolina and affiliates in San Francisco, London, Munich, Geneva and Tokyo. The Group specializes in making private equity investments and in providing strategic assistance to medical technology and life science companies globally.

Recent Milestones

edit

• 
  Nexus Medical Partners invested in KIYATEC. (5/23/12)
  Posted 5/23/12 at 6:44pm via finsmes.com
• 
  Nexus Medical Partners invested in MyoScience. (3/21/12)
  Posted 3/21/12 at 5:31pm via finsmes.com
• 
  Nexus Medical Partners invested in EyeGate Pharmaceuticals. (3/12/08)
  Posted 12/19/09 at 5:52am via eyegatepharma.com
• 
  Nexus Medical Partners invested in Presidio Pharmaceuticals. (8/29/07)
  Posted 7/24/09 at 12:51am via presidiopharma.com
• 
  Nexus Medical Partners invested in Cequent Pharmaceuticals. (6/18/07)
  Posted 11/12/09 at 5:23pm via cequentpharma.com
• 
  Nexus Medical Partners invested in Neurotech. (11/16/06)
  Posted 4/20/10 at 5:21am via neurotechusa.com

Investments

Videos

Sources

1. KIYATEC Raises Series A Funding (finsmes.com) [edit]
2. Myoscience Closes $33M Series D Financing (finsmes.com) [edit]
3. EYEGATE PHARMA SECURES $15M IN SERIES C VENTURE FUNDING (eyegatepharma.com) [edit]
4. Presidio Pharmaceuticals Closes $26 Million Series B Financing (presidiopharma.com) [edit]
5. Cequent Pharmaceuticals (cequentpharma.com) [edit]
6. Neurotechâ„¢, Inc. Completes $35 Million Private Equity Financing (neurotechusa.com) [edit]